100
Participants
Start Date
December 12, 2023
Primary Completion Date
September 22, 2026
Study Completion Date
September 22, 2026
Dupilumab
Injection solution; subcutaneous
Investigational Site Number : 2500005, Brest
Allergy Center at Brookstone Research - Centricity Research - PPDS- Site Number : 8400025, Columbus
Investigational Site Number : 2500001, Nantes
U.S. Dermatology Partners Lee's Summit- Site Number : 8400016, Lee's Summit
North Texas Center for Clinical Research- Site Number : 8400012, Frisco
U.S. Dermatology Partners Longview- Site Number : 8400032, Longview
Vivida Dermatology - Flamingo- Site Number : 8400013, Las Vegas
Halcyon Dermatology- Site Number : 8400023, Laguna Hills
Center for Dermatology Clinical Research- Site Number : 8400002, Fremont
Investigational Site Number : 1560007, Beijing
Investigational Site Number : 1560005, Beijing
Investigational Site Number : 1560006, Shanghai
Investigational Site Number : 1560003, Jinan
Investigational Site Number : 1560008, Hangzhou
Investigational Site Number : 1560010, Wenzhou
Investigational Site Number : 1560009, Guangzhou
Investigational Site Number : 1560002, Shenzhen
Investigational Site Number : 1560004, Xi'an
Medical Dermatology Specialists Site Number : 8400005, Phoenix
Saguaro Dermatology Associates, LLC - Probity - PPDS- Site Number : 8400024, Phoenix
Mission Dermatology - Rancho Santa Margarita- Site Number : 8400015, Rancho Santa Margarita
Golden State Dermatology- Site Number : 8400014, Walnut Creek
Total Vein And Skin, LLC- Site Number : 8400019, Boynton Beach
GSI Clinical Research- Site Number : 8400017, Margate
Dawes Fretzin Clinical Research Group-7910 N Shadeland Ave- Site Number : 8400003, Indianapolis
Oakland Hills Dermatology - 3400 Auburn Rd- Site Number : 8400007, Auburn Hills
Derm Institute of Western Michigan- Site Number : 8400034, Caledonia
Dermatology Associates Western Michigan- Site Number : 8400033, Grand Rapids
University of Nebraska - Lauritzen Outpatient Center- Site Number : 8400029, Omaha
Las Vegas Dermatology- Site Number : 8400027, Las Vegas
Duke Dermatology Clinic- Site Number : 8400026, Durham
Medical University of South Carolina (MUSC) - PPDS- Site Number : 8400001, Charleston
Texas Tech University Health Sciences Center-125 W Hague Rd- Site Number : 8400010, Lubbock
West Virginia Research Institute- Site Number : 8400030, Morgantown
Investigational Site Number : 1240009, Calgary
Investigational Site Number : 1240007, Edmonton
Investigational Site Number : 1240012, Surrey
Investigational Site Number : 1240006, Fredericton
Investigational Site Number : 1240004, Ajax
Investigational Site Number : 1240003, Barrie
Investigational Site Number : 1240011, London
Investigational Site Number : 1240002, Newmarket
Investigational Site Number : 1240005, Toronto
Investigational Site Number : 1240010, Waterloo
Investigational Site Number : 3920001, Obihiro
Investigational Site Number : 3920003, Kyoto
Investigational Site Number : 3920004, Matsudo
Investigational Site Number : 5280001, Bergen op Zoom
Investigational Site Number : 5280002, Hoofddorp
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY